Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 34 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

26%

9 trials in Phase 3/4

Results Transparency

23%

5 of 22 completed with results

Key Signals

5 with results100% success

Data Visualizations

Phase Distribution

28Total
Not Applicable (10)
P 1 (6)
P 2 (3)
P 3 (3)
P 4 (6)

Trial Status

Completed22
Recruiting6
Unknown3
Not Yet Recruiting2
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 22 completed trials

Clinical Trials (34)

Showing 20 of 20 trials
NCT07729137Phase 2Not Yet RecruitingPrimary

Study of EO2002 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction

NCT07368959Phase 3RecruitingPrimary

AURN001 Efficacy in Participants With Corneal Edema Secondary to Corneal Endothelial Dysfunction

NCT07605273Not ApplicableCompletedPrimary

Comparison of 5% Hypertonic Saline Versus 3% Hypertonic Saline in Resolution of Post-operative Corneal Edema.

NCT06261346Not ApplicableRecruiting

Plasma Rich in Growth Factors in Corneal Endothelial Transplantation

NCT07344168Not ApplicableNot Yet RecruitingPrimary

EndoArt® Implantation in Subjects With Chronic Corneal Edema - US Study

NCT05626478Phase 4CompletedPrimary

Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery

NCT07325097Phase 1RecruitingPrimary

PVEK Corneal Implant For Treatment of Corneal Edema

NCT06041256Phase 1CompletedPrimary

A Phase 1/2 Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1)

NCT05636579Phase 1RecruitingPrimary

Study to Assess Safety and Tolerability of Multiple Doses of EO2002

NCT05436665Not ApplicableRecruitingPrimary

The Belgian Endothelial Surgical Transplant of the Cornea

NCT06983652Recruiting

Validation of the Use of Terahertz Scanning System on Corneal Scars and Corneal Edema

NCT04894110Phase 1CompletedPrimary

Study of Safety and Tolerability of EO2002 in the Treatment of Corneal Edema

NCT06630169Phase 2Active Not RecruitingPrimary

Study of Cryopreserved AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction

NCT05956535Completed

Air Optix® Night and Day® Aqua Therapeutic Wear

NCT05139771Not ApplicableCompletedPrimary

EndoArt® Implantation in Subjects With Chronic Corneal Edema

NCT05309135Phase 1CompletedPrimary

A Safety and Efficacy Study of Corneal Injection for Endothelial Dysfunction Using Human Corneal Endothelial Cell Therapy in Subjects With Corneal Edema Secondary to Endothelial Dysfunction

NCT05136443Phase 4Completed

Loteprednol Etabonate 0.25% for Prevention of Cornea Transplant Rejection

NCT04521140Phase 4CompletedPrimary

Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Corneal Transplant Surgery

NCT05891106Completed

AONDA Therapeutic Indication Study I

NCT04498169Phase 2CompletedPrimary

A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy

Scroll to load more

Research Network

Activity Timeline